Resistance to TRAIL in non-transformed cells is due to multiple redundant pathwaysMarianne van Dijk, Éva Szegezdi|Cell Death and Disease|2013Cited by 72
Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell linesDevalingam Mahalingam, Éva Szegezdi|British Journal of Cancer|2009Cited by 41
TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and AktÉva Szegezdi, Afshin Samali|British Journal of Cancer|2006Cited by 34
Targeting AML through DR4 with a novel variant of rhTRAILÉva Szegezdi, Afshin Samali|Journal of Cellular and Molecular Medicine|2010Cited by 23
Recreating the Bone Marrow Microenvironment to Model Leukemic Stem Cell QuiescenceEimear O’Reilly, Éva Szegezdi|Frontiers in Cell and Developmental Biology|2021Cited by 8